Saudi FDA updates guideline on device marketing authorisation procedures
This article was originally published in Clinica
The Saudi Food and Drug Authority has updated its guidance on medical device marketing authorisation procedures to clarify, among other things, the requirements for cases where more than one device type is grouped or bundled in a single application procedure.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.